• Age between 30 and 45 years 
• Knowledge and at least 3 years’ experience in clinical radiation oncology or medical oncologists with basic knowledge in radiotherapy
• Involvement in scientific activities
• Fluency in English 

Application and Selection Procedure

Interested radiotherapists or clinical oncologists with knowledge in radiation therapy should fill in the application form (available at www.eso.net or at www.estro.org ) and provide:

• Letter describing motivation for attending
• CV with list of publications
• Supporting letter from Head of Department or Mentor
•  An abstract and a research proposal relating to one of the subjects of the Masterclass (head and neck, prostate, colorectal, lung cancers) 

The abstract (max. 1 page) should describe a clinical case in the form of a clinical grand-round. 

The research proposal (1 page) should not be a protocol but a description of an interesting future research perspective relating to one of the subjects of the Masterclass.

APPLICATION DEADLINE: 30 JUNE 2012.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT chiara.gasparotto@estro.org  

Educational Programme

Saturday 3 November 2012 - General Sessions
Participants' arrival and registrations
§   Recent radiobiological discoveries: trends for translational research in the coming years
§   Recent improvement in medical physics: treatment planning and delivery
§   Specific research designs for evidence-based radiation oncology 

Sunday 4 November 2012 - General Sessions
§   New systemic therapies from a medical oncologist’s perspective, and from a radiation
oncologist’s perspective
§   Imaging in oncology: what can we really see today?
§   Image-guided radiotherapy 

Monday 5 November 2012 - Non-Small Cell Lung Cancer
§   Integrating biology in the treatment planning of lung cancer: Any options for therapeutic gain or dead end?
§   Image guidance in decision making and radiotherapy
§   Systemic treatments: what are we heading for?
§   Multimodality: do we really need a surgeon?
§   Pathologist commentary

 Tuesday 6 November 2012 – Prostate Cancer
§   Treatment decision: risk factors, nomograms and what else?
§   Impact of imaging on treatment strategy and planning: ultrasound, CT, MRI, PET-CT – What and when?
§   Evidence-based radical prostatectomy: results and side-effects in early and advanced disease
§   Hormonal therapy, chemotherapy, biologicals: balance between effects and morbidity
§   How to understand the biology of radiation effects in various risk settings and treatment schedules
§   3D-CRT, IMRT, IGRT and more? From progress in technology to progress in outcome
§   Image-guided LDR and HDR brachytherapy: Potential and evidence - Monotherapy and combination therapy
§   Pathologist commentary 

Wednesday 7 November 2012 – Head and Neck Cancer
§   Pathology: towards the molecular era?
§   Organ preservation versus primary surgery: when and for whom?
§   From biology to physics and clinical radiotherapy: how to integrate the recent translational research findings in clinics?
§   Systemic treatments: what are we heading for? 

Thursday 8 November 2012 – Colorectal Cancer
§   Evidences and perspectives in clinical staging
§   New endpoints in radiotherapy targeting
§   The preoperative approach
§   Perspectives in the combination with new drugs
§   Pathologist commentary